Xiaomei Li

机构：Wenzhou University, Université Paris-Saclay, Ningbo No. 2 Hospital, Medical Center Hospital, Shanxi Academy of Building Research, Lanzhou University Second Hospital, Xi’an International University, Shanghai Sixth People's Hospital, Qilu Hospital of Shandong University, Ningbo No.6 Hospital, Hôpital Paul-Brousse, University of Chinese Academy of Sciences, Shandong Center for Disease Control and Prevention, East China Normal University, Lanzhou University · ORCID：0000-0001-6505-3363

发表论文 105 篇 · 总被引 1673 次 · h-index 20

代表论文

• Review of ion doping and intercalation strategies for advancing manganese-based oxide cathodes in aqueous zinc-ion batteries (2025 · Nano Energy · 被引 91)
• Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study (2025 · EBioMedicine · 被引 46)
• Formononetin attenuates cigarette smoke‐induced COPD in mice by suppressing inflammation, endoplasmic reticulum stress, and apoptosis in bronchial epithelial cells via AhR / CYP1A1 and AKT / mTOR signaling pathways (2024 · Phytotherapy Research · 被引 30)
• TRIM21-NUP98 Interface Accommodates Structurally Diverse Molecular Glue Degraders (2025 · ACS Chemical Biology · 被引 15)
• ZX703: A Small-Molecule Degrader of GPX4 Inducing Ferroptosis in Human Cancer Cells (2024 · ACS Medicinal Chemistry Letters · 被引 15)
• RETRACTED: Randomized trial of relevance of time-of-day of immunochemotherapy for progression-free and overall survival in patients with non-small cell lung cancer. (2025 · Journal of Clinical Oncology · 被引 13)